The Effect of Zinc Salts on Serum Bilirubin Levels in Hyperbilirubinemic Rats

ABSTRACT Objectives: Intestinal metabolism of bilirubin is implicated in the pathogenesis of neonatal jaundice and Crigler‐Najjar syndrome. In the present study the authors investigated the effect of oral administration of zinc salts on serum bilirubin levels in hyperbilirubinemic rats. Methods: Bil...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pediatric gastroenterology and nutrition 2005-02, Vol.40 (2), p.135-140
Hauptverfasser: Vítek, Libor, Muchová, Lucie, Zelenka, Jaroslav, Zadinová, Marie, Malina, Jiří
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 140
container_issue 2
container_start_page 135
container_title Journal of pediatric gastroenterology and nutrition
container_volume 40
creator Vítek, Libor
Muchová, Lucie
Zelenka, Jaroslav
Zadinová, Marie
Malina, Jiří
description ABSTRACT Objectives: Intestinal metabolism of bilirubin is implicated in the pathogenesis of neonatal jaundice and Crigler‐Najjar syndrome. In the present study the authors investigated the effect of oral administration of zinc salts on serum bilirubin levels in hyperbilirubinemic rats. Methods: Bilirubin‐binding activities of zinc sulfate and water‐insoluble zinc methacrylate were determined in vitro. Congenitally hyperbilirubinemic Gunn rats and artificially hyperbilirubinemic Wistar rats were used in in vivo studies. Animals were fed a normal diet for 1 week and then a treatment diet of either zinc sulfate or zinc methacrylate for additional 2 weeks. Serum and fecal bile pigments were determined at the end of each phase. Biliary bilirubin secretion rates were determined in hyperbilirubinemic Wistar rats fed zinc methacrylate. Results: Substantial bilirubin‐binding activities of zinc salts were demonstrated in in vitro experiments. Treatment with oral zinc salts significantly decreased serum bilirubin levels in Gunn rats (166 ± 53 versus 123 ± 38 and 206 ± 34 versus 131 ± 31 μmol/L, P < 0.05 for zinc methacrylate and zinc sulfate, respectively). A similar effect of zinc methacrylate was also observed in hyperbilirubinemic Wistar rats (102 ± 10 versus 14 ± 4 μmol/L, P < 0.0001). In accord, biliary bilirubin secretion decreased significantly in these animals (45 ± 11 versus 28 ± 4 nmol/h 100g body weight, P < 0.02). In contrast to zinc sulfate, treatment with zinc methacrylate did not lead to the elevation of serum zinc levels. Conclusions: Oral administration of zinc salts efficiently decreased serum bilirubin levels in hyperbilirubinemic rats, presumably as a result of inhibition of enterohepatic circulation of bilirubin. This approach might be useful in the treatment of severe unconjugated hyperbilirubinemias.
doi_str_mv 10.1002/j.1536-4801.2005.tb00952.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67418667</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67418667</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3820-1e36fd6be2531f113e0f0e264cff6773bdbe90999a282df798a485278472725c3</originalsourceid><addsrcrecordid>eNqVkU1v1DAQhi0EokvhLyALCW4JYye2Y2501dKi5UO0XLhYjneszeJstnZCu_--iTbQMwd_SH7emdFjQt4wyBkAf7_NmShkVlbAcg4g8r4G0ILn90_I4t_TU7IArlTGGZMn5EVKWwBQpYDn5IQJqbWsxIJ8udkgPfceXU87T381O0evbegT7Xb0GuPQ0rMmNHGomx1d4R8MiY63y8MeY_33AdvG0R-2Ty_JM29DwlfzeUp-XpzfLC-z1bdPV8uPq8wVFYeMYSH9WtbIRcE8YwWCB-SydN5LpYp6XaMGrbXlFV97pStbVoKrqlRcceGKU_LuWHcfu9sBU2_aJjkMwe6wG5KRqmSVlGoEPxxBF7uUInqzj01r48EwMJNMszWTMTMZM5NMM8s092P49dxlqFtcP0ZneyPwdgZscjb4aHeuSY-cnKqyaYryyN11oceYfofhDqPZ4Ch6Y8ZvAcGUzKb2MG6QjYvBGFvOsSbg4T8mN5-_fy3OLoBrrosHvU2giA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67418667</pqid></control><display><type>article</type><title>The Effect of Zinc Salts on Serum Bilirubin Levels in Hyperbilirubinemic Rats</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Journals@Ovid Ovid Autoload</source><creator>Vítek, Libor ; Muchová, Lucie ; Zelenka, Jaroslav ; Zadinová, Marie ; Malina, Jiří</creator><creatorcontrib>Vítek, Libor ; Muchová, Lucie ; Zelenka, Jaroslav ; Zadinová, Marie ; Malina, Jiří</creatorcontrib><description>ABSTRACT Objectives: Intestinal metabolism of bilirubin is implicated in the pathogenesis of neonatal jaundice and Crigler‐Najjar syndrome. In the present study the authors investigated the effect of oral administration of zinc salts on serum bilirubin levels in hyperbilirubinemic rats. Methods: Bilirubin‐binding activities of zinc sulfate and water‐insoluble zinc methacrylate were determined in vitro. Congenitally hyperbilirubinemic Gunn rats and artificially hyperbilirubinemic Wistar rats were used in in vivo studies. Animals were fed a normal diet for 1 week and then a treatment diet of either zinc sulfate or zinc methacrylate for additional 2 weeks. Serum and fecal bile pigments were determined at the end of each phase. Biliary bilirubin secretion rates were determined in hyperbilirubinemic Wistar rats fed zinc methacrylate. Results: Substantial bilirubin‐binding activities of zinc salts were demonstrated in in vitro experiments. Treatment with oral zinc salts significantly decreased serum bilirubin levels in Gunn rats (166 ± 53 versus 123 ± 38 and 206 ± 34 versus 131 ± 31 μmol/L, P &lt; 0.05 for zinc methacrylate and zinc sulfate, respectively). A similar effect of zinc methacrylate was also observed in hyperbilirubinemic Wistar rats (102 ± 10 versus 14 ± 4 μmol/L, P &lt; 0.0001). In accord, biliary bilirubin secretion decreased significantly in these animals (45 ± 11 versus 28 ± 4 nmol/h 100g body weight, P &lt; 0.02). In contrast to zinc sulfate, treatment with zinc methacrylate did not lead to the elevation of serum zinc levels. Conclusions: Oral administration of zinc salts efficiently decreased serum bilirubin levels in hyperbilirubinemic rats, presumably as a result of inhibition of enterohepatic circulation of bilirubin. This approach might be useful in the treatment of severe unconjugated hyperbilirubinemias.</description><identifier>ISSN: 0277-2116</identifier><identifier>EISSN: 1536-4801</identifier><identifier>DOI: 10.1002/j.1536-4801.2005.tb00952.x</identifier><identifier>PMID: 15699685</identifier><identifier>CODEN: JPGND6</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins, Inc</publisher><subject>Administration, Oral ; Animals ; Astringents ; Bile Acids and Salts - analysis ; bilirubin ; Bilirubin - pharmacokinetics ; Biological and medical sciences ; Crigler-Najjar Syndrome - drug therapy ; Crigler‐Najjar syndrome ; Disease Models, Animal ; Feeding. Feeding behavior ; Fundamental and applied biological sciences. Psychology ; Gunn rats ; Humans ; Hyperbilirubinemia - blood ; Hyperbilirubinemia - drug therapy ; Male ; Methacrylates - administration &amp; dosage ; Methacrylates - pharmacology ; neonatal jaundice ; Rats ; Rats, Gunn ; Rats, Wistar ; Solubility ; Vertebrates: anatomy and physiology, studies on body, several organs or systems ; zinc salts ; Zinc Sulfate - administration &amp; dosage ; Zinc Sulfate - pharmacology</subject><ispartof>Journal of pediatric gastroenterology and nutrition, 2005-02, Vol.40 (2), p.135-140</ispartof><rights>2005 by European Society for European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition</rights><rights>2005 Lippincott Williams &amp; Wilkins, Inc.</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3820-1e36fd6be2531f113e0f0e264cff6773bdbe90999a282df798a485278472725c3</citedby><cites>FETCH-LOGICAL-c3820-1e36fd6be2531f113e0f0e264cff6773bdbe90999a282df798a485278472725c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fj.1536-4801.2005.tb00952.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fj.1536-4801.2005.tb00952.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,778,782,1414,27907,27908,45557,45558</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16480117$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15699685$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vítek, Libor</creatorcontrib><creatorcontrib>Muchová, Lucie</creatorcontrib><creatorcontrib>Zelenka, Jaroslav</creatorcontrib><creatorcontrib>Zadinová, Marie</creatorcontrib><creatorcontrib>Malina, Jiří</creatorcontrib><title>The Effect of Zinc Salts on Serum Bilirubin Levels in Hyperbilirubinemic Rats</title><title>Journal of pediatric gastroenterology and nutrition</title><addtitle>J Pediatr Gastroenterol Nutr</addtitle><description>ABSTRACT Objectives: Intestinal metabolism of bilirubin is implicated in the pathogenesis of neonatal jaundice and Crigler‐Najjar syndrome. In the present study the authors investigated the effect of oral administration of zinc salts on serum bilirubin levels in hyperbilirubinemic rats. Methods: Bilirubin‐binding activities of zinc sulfate and water‐insoluble zinc methacrylate were determined in vitro. Congenitally hyperbilirubinemic Gunn rats and artificially hyperbilirubinemic Wistar rats were used in in vivo studies. Animals were fed a normal diet for 1 week and then a treatment diet of either zinc sulfate or zinc methacrylate for additional 2 weeks. Serum and fecal bile pigments were determined at the end of each phase. Biliary bilirubin secretion rates were determined in hyperbilirubinemic Wistar rats fed zinc methacrylate. Results: Substantial bilirubin‐binding activities of zinc salts were demonstrated in in vitro experiments. Treatment with oral zinc salts significantly decreased serum bilirubin levels in Gunn rats (166 ± 53 versus 123 ± 38 and 206 ± 34 versus 131 ± 31 μmol/L, P &lt; 0.05 for zinc methacrylate and zinc sulfate, respectively). A similar effect of zinc methacrylate was also observed in hyperbilirubinemic Wistar rats (102 ± 10 versus 14 ± 4 μmol/L, P &lt; 0.0001). In accord, biliary bilirubin secretion decreased significantly in these animals (45 ± 11 versus 28 ± 4 nmol/h 100g body weight, P &lt; 0.02). In contrast to zinc sulfate, treatment with zinc methacrylate did not lead to the elevation of serum zinc levels. Conclusions: Oral administration of zinc salts efficiently decreased serum bilirubin levels in hyperbilirubinemic rats, presumably as a result of inhibition of enterohepatic circulation of bilirubin. This approach might be useful in the treatment of severe unconjugated hyperbilirubinemias.</description><subject>Administration, Oral</subject><subject>Animals</subject><subject>Astringents</subject><subject>Bile Acids and Salts - analysis</subject><subject>bilirubin</subject><subject>Bilirubin - pharmacokinetics</subject><subject>Biological and medical sciences</subject><subject>Crigler-Najjar Syndrome - drug therapy</subject><subject>Crigler‐Najjar syndrome</subject><subject>Disease Models, Animal</subject><subject>Feeding. Feeding behavior</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gunn rats</subject><subject>Humans</subject><subject>Hyperbilirubinemia - blood</subject><subject>Hyperbilirubinemia - drug therapy</subject><subject>Male</subject><subject>Methacrylates - administration &amp; dosage</subject><subject>Methacrylates - pharmacology</subject><subject>neonatal jaundice</subject><subject>Rats</subject><subject>Rats, Gunn</subject><subject>Rats, Wistar</subject><subject>Solubility</subject><subject>Vertebrates: anatomy and physiology, studies on body, several organs or systems</subject><subject>zinc salts</subject><subject>Zinc Sulfate - administration &amp; dosage</subject><subject>Zinc Sulfate - pharmacology</subject><issn>0277-2116</issn><issn>1536-4801</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkU1v1DAQhi0EokvhLyALCW4JYye2Y2501dKi5UO0XLhYjneszeJstnZCu_--iTbQMwd_SH7emdFjQt4wyBkAf7_NmShkVlbAcg4g8r4G0ILn90_I4t_TU7IArlTGGZMn5EVKWwBQpYDn5IQJqbWsxIJ8udkgPfceXU87T381O0evbegT7Xb0GuPQ0rMmNHGomx1d4R8MiY63y8MeY_33AdvG0R-2Ty_JM29DwlfzeUp-XpzfLC-z1bdPV8uPq8wVFYeMYSH9WtbIRcE8YwWCB-SydN5LpYp6XaMGrbXlFV97pStbVoKrqlRcceGKU_LuWHcfu9sBU2_aJjkMwe6wG5KRqmSVlGoEPxxBF7uUInqzj01r48EwMJNMszWTMTMZM5NMM8s092P49dxlqFtcP0ZneyPwdgZscjb4aHeuSY-cnKqyaYryyN11oceYfofhDqPZ4Ch6Y8ZvAcGUzKb2MG6QjYvBGFvOsSbg4T8mN5-_fy3OLoBrrosHvU2giA</recordid><startdate>200502</startdate><enddate>200502</enddate><creator>Vítek, Libor</creator><creator>Muchová, Lucie</creator><creator>Zelenka, Jaroslav</creator><creator>Zadinová, Marie</creator><creator>Malina, Jiří</creator><general>Lippincott Williams &amp; Wilkins, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200502</creationdate><title>The Effect of Zinc Salts on Serum Bilirubin Levels in Hyperbilirubinemic Rats</title><author>Vítek, Libor ; Muchová, Lucie ; Zelenka, Jaroslav ; Zadinová, Marie ; Malina, Jiří</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3820-1e36fd6be2531f113e0f0e264cff6773bdbe90999a282df798a485278472725c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Administration, Oral</topic><topic>Animals</topic><topic>Astringents</topic><topic>Bile Acids and Salts - analysis</topic><topic>bilirubin</topic><topic>Bilirubin - pharmacokinetics</topic><topic>Biological and medical sciences</topic><topic>Crigler-Najjar Syndrome - drug therapy</topic><topic>Crigler‐Najjar syndrome</topic><topic>Disease Models, Animal</topic><topic>Feeding. Feeding behavior</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gunn rats</topic><topic>Humans</topic><topic>Hyperbilirubinemia - blood</topic><topic>Hyperbilirubinemia - drug therapy</topic><topic>Male</topic><topic>Methacrylates - administration &amp; dosage</topic><topic>Methacrylates - pharmacology</topic><topic>neonatal jaundice</topic><topic>Rats</topic><topic>Rats, Gunn</topic><topic>Rats, Wistar</topic><topic>Solubility</topic><topic>Vertebrates: anatomy and physiology, studies on body, several organs or systems</topic><topic>zinc salts</topic><topic>Zinc Sulfate - administration &amp; dosage</topic><topic>Zinc Sulfate - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vítek, Libor</creatorcontrib><creatorcontrib>Muchová, Lucie</creatorcontrib><creatorcontrib>Zelenka, Jaroslav</creatorcontrib><creatorcontrib>Zadinová, Marie</creatorcontrib><creatorcontrib>Malina, Jiří</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pediatric gastroenterology and nutrition</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vítek, Libor</au><au>Muchová, Lucie</au><au>Zelenka, Jaroslav</au><au>Zadinová, Marie</au><au>Malina, Jiří</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Effect of Zinc Salts on Serum Bilirubin Levels in Hyperbilirubinemic Rats</atitle><jtitle>Journal of pediatric gastroenterology and nutrition</jtitle><addtitle>J Pediatr Gastroenterol Nutr</addtitle><date>2005-02</date><risdate>2005</risdate><volume>40</volume><issue>2</issue><spage>135</spage><epage>140</epage><pages>135-140</pages><issn>0277-2116</issn><eissn>1536-4801</eissn><coden>JPGND6</coden><abstract>ABSTRACT Objectives: Intestinal metabolism of bilirubin is implicated in the pathogenesis of neonatal jaundice and Crigler‐Najjar syndrome. In the present study the authors investigated the effect of oral administration of zinc salts on serum bilirubin levels in hyperbilirubinemic rats. Methods: Bilirubin‐binding activities of zinc sulfate and water‐insoluble zinc methacrylate were determined in vitro. Congenitally hyperbilirubinemic Gunn rats and artificially hyperbilirubinemic Wistar rats were used in in vivo studies. Animals were fed a normal diet for 1 week and then a treatment diet of either zinc sulfate or zinc methacrylate for additional 2 weeks. Serum and fecal bile pigments were determined at the end of each phase. Biliary bilirubin secretion rates were determined in hyperbilirubinemic Wistar rats fed zinc methacrylate. Results: Substantial bilirubin‐binding activities of zinc salts were demonstrated in in vitro experiments. Treatment with oral zinc salts significantly decreased serum bilirubin levels in Gunn rats (166 ± 53 versus 123 ± 38 and 206 ± 34 versus 131 ± 31 μmol/L, P &lt; 0.05 for zinc methacrylate and zinc sulfate, respectively). A similar effect of zinc methacrylate was also observed in hyperbilirubinemic Wistar rats (102 ± 10 versus 14 ± 4 μmol/L, P &lt; 0.0001). In accord, biliary bilirubin secretion decreased significantly in these animals (45 ± 11 versus 28 ± 4 nmol/h 100g body weight, P &lt; 0.02). In contrast to zinc sulfate, treatment with zinc methacrylate did not lead to the elevation of serum zinc levels. Conclusions: Oral administration of zinc salts efficiently decreased serum bilirubin levels in hyperbilirubinemic rats, presumably as a result of inhibition of enterohepatic circulation of bilirubin. This approach might be useful in the treatment of severe unconjugated hyperbilirubinemias.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins, Inc</pub><pmid>15699685</pmid><doi>10.1002/j.1536-4801.2005.tb00952.x</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0277-2116
ispartof Journal of pediatric gastroenterology and nutrition, 2005-02, Vol.40 (2), p.135-140
issn 0277-2116
1536-4801
language eng
recordid cdi_proquest_miscellaneous_67418667
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Journals@Ovid Ovid Autoload
subjects Administration, Oral
Animals
Astringents
Bile Acids and Salts - analysis
bilirubin
Bilirubin - pharmacokinetics
Biological and medical sciences
Crigler-Najjar Syndrome - drug therapy
Crigler‐Najjar syndrome
Disease Models, Animal
Feeding. Feeding behavior
Fundamental and applied biological sciences. Psychology
Gunn rats
Humans
Hyperbilirubinemia - blood
Hyperbilirubinemia - drug therapy
Male
Methacrylates - administration & dosage
Methacrylates - pharmacology
neonatal jaundice
Rats
Rats, Gunn
Rats, Wistar
Solubility
Vertebrates: anatomy and physiology, studies on body, several organs or systems
zinc salts
Zinc Sulfate - administration & dosage
Zinc Sulfate - pharmacology
title The Effect of Zinc Salts on Serum Bilirubin Levels in Hyperbilirubinemic Rats
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T18%3A50%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Effect%20of%20Zinc%20Salts%20on%20Serum%20Bilirubin%20Levels%20in%20Hyperbilirubinemic%20Rats&rft.jtitle=Journal%20of%20pediatric%20gastroenterology%20and%20nutrition&rft.au=V%C3%ADtek,%20Libor&rft.date=2005-02&rft.volume=40&rft.issue=2&rft.spage=135&rft.epage=140&rft.pages=135-140&rft.issn=0277-2116&rft.eissn=1536-4801&rft.coden=JPGND6&rft_id=info:doi/10.1002/j.1536-4801.2005.tb00952.x&rft_dat=%3Cproquest_cross%3E67418667%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67418667&rft_id=info:pmid/15699685&rfr_iscdi=true